Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?
Neurocrine Biosciences Ownership Summary
Neurocrine Biosciences is owned by 86.80% institutional investors, 1.86% insiders, and 11.34% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.62% of NBIX shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.27% of its assets in Neurocrine Biosciences shares.
NBIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurocrine Biosciences | 86.80% | 1.86% | 11.34% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 14.78M | 14.62% | $2.02B |
| Blackrock | 14.19M | 14.22% | $1.95B |
| Vanguard group | 10.12M | 10.01% | $1.38B |
| State street | 4.61M | 4.62% | $634.43M |
| Dodge & cox | 3.02M | 2.98% | $411.74M |
| Renaissance | 2.49M | 2.46% | $339.80M |
| Aqr capital management | 1.90M | 1.88% | $258.93M |
| Geode capital management | 1.88M | 1.85% | $255.52M |
| Bellevue group | 1.82M | 1.80% | $248.43M |
| Morgan stanley | 1.54M | 1.55% | $212.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sarissa capital management lp | 309.12K | 13.07% | $42.19M |
| Eagle health investments lp | 155.00K | 5.19% | $21.16M |
| Bellevue group | 1.82M | 4.78% | $248.43M |
| Healthinvest partners ab | 67.76K | 4.41% | $9.29M |
| Rock springs capital management lp | 720.50K | 3.74% | $98.35M |
| Braidwell lp | 901.79K | 3.65% | $123.09M |
| Birchview capital, lp | 30.24K | 3.36% | $4.13M |
| Logos global management lp | 200.00K | 3.19% | $27.30M |
| Avidity partners management lp | 220.40K | 2.95% | $30.08M |
| Orbimed advisors | 938.12K | 2.64% | $128.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Dodge & cox | 3.02M | 0.24% | 1.73M |
| Raymond james financial | 843.90K | 0.04% | 843.90K |
| Wellington management group llp | 1.46M | 0.04% | 739.20K |
| Thrivent financial for lutherans | 737.77K | 0.20% | 711.97K |
| Armistice capital | 892.00K | 1.66% | 710.62K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -837.43K |
| Vestal point capital, lp | - | - | -710.00K |
| Qube research | 145.11K | 0.03% | -618.24K |
| Jupiter asset management | - | - | -582.79K |
| Morgan stanley | 1.54M | 0.02% | -520.77K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Raymond james financial | 843.90K | 0.04% | 843.90K | $115.19M |
| Norges bank | 325.30K | 0.01% | 325.30K | $44.40M |
| Logos global management lp | 200.00K | 3.19% | 200.00K | $27.30M |
| Balyasny asset management | 194.73K | 0.04% | 194.73K | $26.58M |
| Pfm health sciences, lp | 166.80K | 1.41% | 166.80K | $22.77M |
Sold Out
| Holder | Change |
|---|---|
| Rosenberg matthew hamilton | -4.00 |
| Tfc financial management | -4.00 |
| Dt investment partners | -5.00 |
| Financial synergies wealth advisors | -9.00 |
| Johnson financial group | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 555 | -5.77% | 87,755,246 | -5.34% | 86 | 1.03% | 288 | -3.36% | 196 | -2.97% |
| Sep 30, 2024 | 585 | -3.31% | 92,570,293 | -1.20% | 91 | 1.06% | 297 | -9.17% | 200 | 6.38% |
| Jun 30, 2024 | 596 | -0.83% | 93,638,169 | 0.75% | 93 | 1.08% | 321 | 1.90% | 187 | -10.10% |
| Mar 31, 2024 | 601 | 7.71% | 92,944,071 | 0.73% | 93 | 1.04% | 315 | 5.35% | 208 | 7.22% |
| Dec 31, 2023 | 558 | 6.90% | 92,268,184 | 0.48% | 94 | 1.07% | 299 | 21.54% | 194 | -1.52% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.26M | 3.27% | 5.70K |
| Vanguard US Total Market Shares ETF | 3.20M | 3.21% | 2.53K |
| Vanguard Total Stock Mkt Idx Inv | 3.19M | 3.20% | 1.79K |
| Vanguard Small Cap Index | 2.58M | 2.59% | 2.10K |
| Dodge & Cox Stock I | 2.07M | 2.04% | 1.37M |
| BB Biotech AG Ord | 1.82M | 1.80% | -40.00K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.54M | 1.54% | 4.87K |
| Vanguard Small Cap Growth Index Inv | 1.45M | 1.46% | -6.01K |
| SPDR® S&P Biotech ETF | 1.21M | 1.22% | -13.01K |
| SPDR® S&P MIDCAP 400 ETF Trust | 817.96K | 0.82% | 7.78K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 13, 2025 | Cooke Julie | Chief Human Resources Officer | Sell | $92.95K |
| Feb 13, 2025 | Cooke Julie | Chief Human Resources Officer | Sell | $88.18K |
| Feb 13, 2025 | GORMAN KEVIN CHARLES | - | Sell | $351.45K |
| Feb 13, 2025 | GORMAN KEVIN CHARLES | - | Sell | $330.46K |
| Feb 13, 2025 | SHERWIN STEPHEN A | - | Sell | $1.61M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 45 |
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 18 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | 67 |
NBIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools